CVE-2019-10354

Description

A vulnerability in the Stapler web framework used in Jenkins 2.185 and earlier, LTS 2.176.1 and earlier allowed attackers to access view fragments directly, bypassing permission checks and possibly obtain sensitive information.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.22%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory jenkins.io
Affected: Jenkins project Jenkins
Published at:
Updated at:

References

Link Tags
http://www.openwall.com/lists/oss-security/2019/07/17/2 third party advisory mailing list
http://www.securityfocus.com/bid/109373 vdb entry third party advisory
https://access.redhat.com/errata/RHSA-2019:2503 third party advisory vendor advisory
https://access.redhat.com/errata/RHSA-2019:2548 third party advisory vendor advisory
https://jenkins.io/security/advisory/2019-07-17/#SECURITY-534 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2019-10354?
CVE-2019-10354 has been scored as a medium severity vulnerability.
How to fix CVE-2019-10354?
To fix CVE-2019-10354, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-10354 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-10354 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-10354?
CVE-2019-10354 affects Jenkins project Jenkins.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.